OncoGenex Pharmaceuticals, Inc. (OGXI) Reports Q4 Loss of $0.28
Get Alerts OGXI Hot Sheet
Join SI Premium – FREE
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) reported Q4 EPS of ($0.28), versus consensus of ($0.50).
For earnings history and earnings-related data on OncoGenex Pharmaceuticals, Inc. (OGXI) click here.
For earnings history and earnings-related data on OncoGenex Pharmaceuticals, Inc. (OGXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Owlet (OWLT) Tops Q2 EPS by 9c
- Transact Technologies (TACT) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share